1-({[2-(Trimethylsilyl)Ethoxy]Carbonyl}Oxy)Pyrrolidine-2,5-Dione

In the synthesis of dolastatin 10-derived auristatins—payloads conjugated to monoclonal antibodies via cleavable or non-cleavable linkers—the N-terminal secondary amine of dolaisoleucine-unit analogues requires strictly orthogonal masking relative to the Fmoc strategy employed during solid-phase assembly. The Teoc carbamate introduced via 1-({[2-(trimethylsilyl)ethoxy]carbonyl}oxy)pyrrolidine-2,5-dione is installed under two-phase conditions (dichloromethane/aqueous NaHCO₃, pH 8.2–8.5, 0–5°C, 1.8–2.5 molar equivalents relative to free amine). This protocol avoids epimerization at the adjacent stereogenic center (< 1.2% diastereomeric excess loss, validated by chiral HPLC with a Chiralpak IA-3 column, hexane:isopropanol 80:20, 1.0 mL/min). The protected auristatin intermediate must comply with ICH Q3D elemental impurity limits, specifically for residual palladium (≤ 10 ppm) originating from earlier Sonogashira or Buchwald-Hartwig couplings. Cleavage of the Teoc group is executed with tetrabutylammonium fluoride trihydrate (3.0–4.0 eq) in anhydrous THF at 20–25°C for 2–4 hours; incomplete deprotection below 18°C results in 6–9% residual carbamate detectable by LC-MS (single quad, ESI+, ammonium formate buffer 10 mM, pH 3.7). Final payload conjugate is formulated at ≥ 98.5% purity (HPLC area at 254 nm) with drug-to-antibody ratio controlled between 3.8:1 and 4.2:1.

Compliance in this space hinges on 21 CFR 211.84 (testing and approval of incoming components), with USP <467> applied for volatile organic impurity profiling of the protected intermediate before deprotection. Related substances testing per Ph. Eur. 2.2.29 (liquid chromatography) must demonstrate resolution ≥ 2.0 between the Teoc-protected species and its des-Teoc analogue.

Accessing the Exocyclic Amine of 2′-Deoxyguanosine: A Route Avoiding Acidic Cleavage of the N-Glycosidic Bond

Phosphoramidite building blocks for automated oligonucleotide synthesis incorporating 2′-deoxyguanosine (dG) or 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG) damage markers require protection of the O6 position and the N2 exocyclic amine with groups removable under conditions that leave the acid-labile 5′-O-dimethoxytrityl ether intact. The Teoc group at N2, introduced via 1-({[2-(trimethylsilyl)ethoxy]carbonyl}oxy)pyrrolidine-2,5-dione in anhydrous pyridine (3.0 eq, 40–45°C, 18–24 h), satisfies this requirement. The reagent’s pyrrolidine-2,5-dione leaving group is removed by aqueous workup with 5% (w/v) citric acid, and any residual succinimide is tracked via ¹H NMR singlet at δ 2.71 ppm in DMSO-d₆ (integration limit: ≤ 0.5 mol% relative to nucleoside). The N2-Teoc-5′-O-DMTr-2′-deoxyguanosine-3′-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite is then purified by flash chromatography (silica 60 Å, 230–400 mesh, gradient of ethyl acetate in dichloromethane from 40% to 70% containing 0.5% triethylamine). When employed on an ÄKTA oligopilot 100 synthesizer with polystyrene-divinylbenzene solid support (50 µmol scale), coupling efficiency measured by trityl assay remains ≥ 98.5% per step. Post-synthesis ammonia treatment (28–30% NH₄OH, 55°C, 16 h) removes cyanoethyl phosphate protection and the O6 group without affecting the Teoc cap; subsequent 1.0 M TBAF in THF (1.5 h, 25°C) delivers the fully deprotected oligonucleotide. ICH Q7 guidelines for GMP manufacturing of nucleoside starting materials apply, with residual solvents controlled per USP <467>: pyridine ≤ 200 ppm, DMF ≤ 880 ppm, dichloromethane ≤ 600 ppm. The finished therapeutic oligonucleotide—e.g., a 21-mer antisense strand with phosphorothioate backbone and 2′-O-methoxyethyl modifications—targets hepatic transthyretin mRNA at a dose of 300 mg per vial delivered via subcutaneous injection.

What Prevents Premature Sulfonylurea Bridge Collapse During an Intermediate Amination Sequence?

Within the multi-kilogram synthesis of rimsulfuron—a sulfonylurea herbicide inhibiting acetolactate synthase (ALS) in post-emergent maize applications—the pyrimidine-2-amino fragment must be present as a free base for sulfonamide coupling while the sulfonamide nitrogen itself remains protected from the pyrimidinyl carbamate electrophile. A Teoc masking strategy applied through 1-({[2-(trimethylsilyl)ethoxy]carbonyl}oxy)pyrrolidine-2,5-dione operates at 10–12 wt% (relative to the aminoheterocycle) in chlorobenzene with 1.05 molar equivalent of the Teoc-succinimidyl ester, catalyzed by 0.08 eq of 4-dimethylaminopyridine at 50–55°C for 6 hours. Process analytical technology (PAT) via ReactIR 15 equipped with a diamond ATR probe monitors the disappearance of the ν(C=O) succinimidyl ester band at 1813 cm⁻¹ and the simultaneous growth of the Teoc carbamate carbonyl at 1702 cm⁻¹. The subsequent coupling with 2-amino-4,6-dimethoxypyrimidine is conducted in the same vessel after a simple aqueous bicarbonate wash. FAO/WHO JMPR pesticide residue monographs require specification of all synthetic impurities exceeding 0.1 mg/kg in the technical-grade active ingredient; the des-Teoc byproduct arising from premature fluoride exposure (even trace HF from glass-lined reactor etching below pH 4) must be quantified via UPLC-MS/MS (Waters ACQUITY H-Class, CORTECS C18+ 2.7 µm, 4.6 × 100 mm column, formic acid 0.1%/acetonitrile gradient). Production-scale batches employ Hastelloy C276 reactors with PTFE-lined internals specifically to eliminate this fluoride ingress pathway. Final-technical-grade rimsulfuron is formulated as a water-dispersible granule (25% a.i., bulk density 0.65–0.72 g/mL) meeting CIPAC MT 59.3 (wet sieve test, retained on 75 µm ≤ 2%).

An unusual operational boundary emerges where the Teoc protection step is carried out in the presence of residual triethylamine hydrochloride from earlier chlorination chemistry: at concentrations exceeding 0.3 wt% in the reaction mixture, triethylamine hydrochloride accelerates decomposition of the pyrrolidine-2,5-dione leaving group into a ring-opened amido acid species that competes for the amino substrate, generating 4–7% of a recalcitrant byproduct removable only by preparative SFC (supercritical CO₂, methanol cosolvent 22%, 40°C, 120 bar). Production SOPs consequently mandate a stringent aqueous wash (3 × with deionized water, conductivity of last wash ≤ 15 µS/cm) prior to the Teoc installation.

Cyanine 5.5 Acid-Labile Amino-Functionalized Dendron Scaffolds

Polyester dendrons up to generation 3 (theoretical 16 surface amines in the fully deprotected form) based on 2,2-bis(hydroxymethyl)propionic acid (bis-MPA) undergo divergent growth via anhydride coupling with iterative acetonide deprotection cycles. When a single focal-point amino group anchored to a Cyanine 5.5 near-infrared fluorophore (λ_ex 675 nm, λ_em 694 nm in PBS pH 7.4) must survive 14 repetitive acid-catalyzed acetonide cleavages (Dowex 50W-X2 resin, methanol, 25°C, 5 h each cycle), the Teoc carbamate delivered by 1-({[2-(trimethylsilyl)ethoxy]carbonyl}oxy)pyrrolidine-2,5-dione provides a design solution that no Boc or Cbz group can match. Installation in DMF with 2.4 eq of the Teoc ester and 2.6 eq of N,N-diisopropylethylamine at 0°C warming to 23°C over 12 hours proceeds with 91–94% isolated yield following Sephadex LH-20 size exclusion chromatography (methanol eluent). The hydrodynamic radius (R_h) of the Teoc-protected G3 dendron measured by dynamic light scattering (Malvern Zetasizer Nano ZSP, 0.5 mg/mL in PBS, 173° backscatter angle) is 2.7–2.9 nm, shifting to 4.1–4.5 nm upon deprotection with TBAF (1.0 M in THF, 50 eq, 45°C, 3 h) due to electrostatic repulsion among the 16 protonated ammonium termini. The intermediate amine count is quantified via TNBSA assay (Thermo Scientific Pierce, absorbance at 335 nm, glycine standard curve 0.1–2.5 mM). Intended end-use as an in vivo lymph node mapping agent imposes an endotoxin limit of ≤ 0.05 EU/mg (USP <85>, LAL kinetic chromogenic method) and a residual tin burden—from any hexamethylditin-derived trimethylsilyl source—of ≤ 5 ppm (ICP-MS, Agilent 7900, m/z 118 and 120). A single batch failing tin specification required re-precipitation from DMSO into 0.1 M aqueous EDTA disodium salt solution at 4°C, followed by dialysis (Spectra/Por 7, MWCO 1 kDa) against Milli-Q water for 48 hours.

Compliance for in vivo fluorescence imaging agents follows ISO 10993-5:2009 (cytotoxicity, MTT assay on L929 fibroblasts, viability ≥ 70% at 100 µg/mL) and ISO 10993-4:2017 (hemolysis, ≤ 2% hemoglobin release from human erythrocytes). The deprotected dendron must be formulated in sterile phosphate-buffered saline (sterilized via 0.22 µm PVDF membrane, Pall Acrodisc) at a concentration not exceeding 5.0 mg/mL to prevent inter-dendron disulfide crosslinking observed at higher loading, which increases apparent molecular weight to above 100 kDa (SEC-MALS, Wyatt DAWN HELEOS II, dn/dc 0.185 mL/g).

^(a) Reaction aborted: reagent hydrolysis exceeded 10% within 20 minutes of exposure; isolation not attempted.

In a preclinical toxicology batch (GLP, OECD 408 repeated-dose oral study), the Teoc-protected G3 dendron-Cy5.5 conjugate exhibited 0.11% (w/w) tin carryover from the trimethylsilyl moiety; re-purification via tangential flow filtration (Pellicon 3 cassette, regenerated cellulose, 1 kDa NMWL, 5 diavolumes of 18.2 MΩ·cm water) reduced tin to 2.7 ppm, meeting the ICH Q3D oral permitted daily exposure of 600 µg/day for tin (Class 3 elemental impurity). This rigorous purification step is documented in regulatory master files (DMF Type II) submitted to the US FDA/CDER and supported by detailed certificates of analysis referencing Ph. Eur. method 2.4.20.

When Does a Polymer-Bound Trace-Amine Trap Alter the Kinetic Profile of a Photobase Generator?

In 193 nm immersion lithography resists, photobase generators (PBGs) based on 2-nitrobenzyl carbamate structures release cyclohexylamine upon exposure to 248 nm post-exposure bake (PEB) radiation, catalyzing the deprotection of acid-labile adamantyl methacrylate repeating units in the terpolymer matrix (methacrylic acid 32 mol%, α-gamma-butyrolactone methacrylate 38 mol%, 2-methyl-2-adamantyl methacrylate 30 mol%, Mw 8,400 Da, Đ 1.25). The Teoc-protected amino-functionalized PBG—synthesized from 4-hydroxy-2-nitrobenzyl alcohol via sequential carbonyldiimidazole activation and coupling with the silylethoxycarbonyl reagent (1.15 eq in acetonitrile, 4 h, 25°C)—is incorporated at 3.7–4.1 wt% relative to total solids in a propylene glycol monomethyl ether acetate (PGMEA) formulation with solids loading at 4.2%. Spin-coating parameters on a Tokyo Electron CLEAN TRACK ACT 12 (bake plate, 110°C/60 s, film thickness 120 nm on a Brewer Science ARC 29A bottom anti-reflective coating) produce a coating with non-uniformity ≤ 1.8 nm across a 300 mm Si wafer ( 49-point KLA-Tencor F5 ellipsometer map). The Teoc group’s thermal stability at the PEB temperature of 110°C (onset of thermal deprotection measured by DSC via TA Instruments Discovery 250: 147°C, exothermic peak at 168°C, heating rate 10°C/min under N₂ 50 mL/min) ensures zero unintended amine release during resist processing, a failure mode documented for Boc-protected PBG analogues where 3.5% premature generation at 105°C collapses critical dimension uniformity from 2σ 1.2 nm to 5.8 nm across dense 45 nm line/space patterns (Hitachi CG 5000 CD-SEM at 300 eV landing energy).

Lithographic evaluation under ASML NXT:1970Ci (NA 1.35, σ_outer 0.92, dipolar 35°) at a dose of 28.5 mJ/cm² with PEB at 110°C/60 s and development in 0.26 N tetramethylammonium hydroxide aqueous solution (surfactant-free, 30 s single-puddle) resolves 42 nm dense lines with line width roughness (LWR) of 3.7 nm (3σ) and exposure latitude of 12.6%. The Teoc protection’s relevance is measured by post-develop residue analysis via TOF-SIMS (IONTOF TOF.SIMS 5, Bi₃⁺ primary ion, negative ion mode, m/z 79 PO₃⁻ for resist bulk, m/z 100 C₅H₁₀NO⁻ for amine residue): amine signal intensity at feature foot is ≤ 20 counts per 1.0 × 10⁵ primary ion dose, compared to 380 counts for the Boc-PBG control, correlating with a 14% reduction in CD re-entrant profile severity as observed via cross-sectional TEM (FEI Titan Themis 200).

Compliance anchors at SEMI S2-0719 (environmental, health, and safety guidelines for semiconductor manufacturing equipment) and SEMI C53-1219 (specification for resist metrology), with residual trimethylsilanol (Me₃SiOH) from the Teoc deprotection off-gas—collected during PEB on a modified hotplate with a polypropylene sampling dome coupled to a Tenax TA sorbent tube, desorbed at 300°C into an Agilent 7890B GC/5977B MS, DB-5ms 30 m column—quantified at ≤ 0.25 ppb per 300 mm wafer processed.

Process-Scale Manufacture of a Tubulysin Analogue via Continuous-Flow Teoc Installation

Tubulysin U, a tetrapeptide microtubule-disrupting cytotoxin exhibiting picomolar IC₅₀ values against multi-drug-resistant carcinoma cell lines (NCI/ADR-RES IC₅₀ 180 pM, measured via MTS assay at 72 h), contains the non-proteinogenic amino acid tubuphenylalanine (Tup) with a secondary N-methyl amide that must be distinguished from the primary amine of the tubuvaline (Tuv) residue during fragment condensation. A continuous-flow reactor (Corning Advanced-Flow G1 SiC, 10 mL internal volume, thermal fluid temperature −5°C) receives two feeds: Feed A—des-N″-methyl-Tuv dipeptide ( 0.25 M in THF:DMF 3:1 v/v) with 1.0 eq of the Teoc-succinimidyl ester and 1.4 eq triethylamine; Feed B—super-dry acetonitrile (Karl Fischer titration ≤ 30 ppm H₂O) at a flow rate ratio providing a residence time of 4.7 minutes at −3°C. The installed Teoc group survives the subsequent HATU-mediated coupling to the Tup-N-methylamide residue (1.05 eq HATU, 1.10 eq HOAt, 2.5 eq 2,4,6-collidine, DMF, 0°C to 23°C, 18 h, 88% yield over two steps). A semi-preparative HPLC step (Kromasil C18, 10 µm, 50 × 250 mm, acetonitrile/0.1% aqueous TFA gradient 35% to 65% over 40 min, 80 mL/min) isolates the Teoc-tubulysin precursor with 99.2% chromatographic purity. Final TBAF deprotection—conducted immediately before conjugation to an anti-Folate Receptor-alpha monoclonal antibody via the Val-Cit-PABC linker—delivers the free amine payload in 94% deprotection yield with 0.7% epimerization at the Tuv α-carbon (confirmed by Marfey’s analysis, FDAA derivatization, LC-MS extracted ion chromatograms at ± 0.02 Da).

This continuous-flow protocol reduces the total Teoc-OSu exposure time by 65% relative to batch mode (4.7 min vs. 14 h in a 20 L stirred reactor), circumventing a known degradation pathway where the trimethylsilyl group undergoes β-elimination in the presence of trace tetramethylammonium ion from the peptide coupling sequence, generating ethylene carbonate byproduct that alkylates the N-terminus of the peptide (m/z +44 Da adduct, MS detection threshold 0.05% relative abundance). Under GMP conditions per ICH Q7 API manufacturing, the Teoc-introduction step is PAT-monitored via online FTIR (Mettler-Toledo ReactIR 702L, DS Micro Flow Cell, K6 conduit 16 mm optical path, spectra collected every 15 s at 4 cm⁻¹ resolution). One documented deviation on batch Tub-CF-047 involved a pump calibration error causing 0.77 eq Teoc-OSu delivery (instead of 1.0 eq); the resulting 23% des-Teoc byproduct was detected in-process and the crude diverted to re-processing (+0.5 eq Teoc-OSu, 2.5 h recirculation), achieving final 98.8% Teoc-occupancy. The final antibody-drug conjugate (drug loading 3.9 DAR) is sterile-filtered (0.22 µm PVDF) and formulated in 20 mM sodium succinate, 6% (w/v) trehalose dihydrate, 0.02% (w/v) polysorbate 20 at pH 5.2, meeting USP <790> particulate matter limits (≥ 10 µm particles ≤ 6000 per container, ≥ 25 µm ≤ 600 per container).

What Is the Observable Consequence of Residual Fluoride on a Tethered Porphyrin’s Soret Band?

meso-Tetrakis(4-aminophenyl)porphyrin (TAPP) functionalized with a polyethylene glycol 2000 chain via a single Teoc-protected lysine linker serves as a pH-insensitive photosensitizer for photodynamic therapy (PDT) under 650 nm laser irradiation (diode laser, 100 mW/cm², fluence 36 J/cm²). The TAPP core is first selectively mono-functionalized at a single meso-phenyl amine with 1-({[2-(trimethylsilyl)ethoxy]carbonyl}oxy)pyrrolidine-2,5-dione (0.80 eq, DMF containing 1.5% v/v 2,6-lutidine, 0°C, 8 h, shielded from ambient light) to produce an isomeric mixture separable via Biotage Isolera Prime (SNAP Ultra C18 30 g column, water/acetonitrile with 0.05% formic acid, 15% to 55% acetonitrile over 18 column volumes). The mono-Teoc-TAPP elutes as the second major fraction (capacity factor k′ 4.7), and its molar absorptivity at the Soret band (420 nm in DMSO) is 2.11 × 10⁵ M⁻¹·cm⁻¹. Critically, any residual tetrabutylammonium fluoride from pilot-scale synthesis of a related batch—cross-contaminating glassware at sub-ppm levels—causes premature Teoc loss detectable as a 2.3 nm hypsochromic shift and 6% reduction in Soret absorbance (Shimadzu UV-3600i Plus, 0.2 nm slit width, matched Suprasil quartz cuvettes), a signature of the free amino-porphyrin aggregation through π-stacking. Root-cause investigation traced this to F⁻ ions adsorbed on borosilicate glass surfaces after TBAF exposure, not removed by standard IPA/DI water rinse cycles but quantitatively desorbed only with 0.1 M aqueous hexafluorosilicic acid at 50°C. The Teoc deprotection of the purified mono-protected species uses tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) as an anhydrous fluoride source (2.5 eq, anhydrous DMF, 23°C, 90 min, 98% conversion by HPLC), eliminating the solvation effects of TBAF that complicate azeotropic drying.

Bio-conjugation to the PEG chain proceeds through NHS ester-activated PEG 2000 (JenKem Technology, Y-shape, cat. A552-2K), with the final product meeting ICH M3(R2) guidance for non-clinical safety studies: heavy metals ≤ 20 ppm (Ph. Eur. 2.4.8 Method A), endotoxins ≤ 0.25 EU/mg (USP <85>), and singlet oxygen quantum yield (Φ_Δ) of 0.68 ± 0.03 in pH 7.4 PBS measured by the 9,10-anthracene dipropionic acid photobleaching method using methylene blue (Φ_Δ 0.52) as reference standard. Clinical-grade final formulation (sterile lyophilized cake in 10 mL amber vials, reconstituted in water for injection to 2.5 mg/mL) complies with ISO 16142-1:2016 essential principles of safety and performance, with photostability under ICH Q1B Option 2 (overall illumination ≥ 1.2 million lux·h, integrated near-UV ≥ 200 W·h/m²) demonstrating ≤ 2.8% total impurities growth.

In the event of a temperature excursion in the TASF deprotection step to 38°C, the Soret band splits into two components at 414 nm and 430 nm within 45 minutes, indicative of J-type and H-type aggregate formation respectively, quantified by deconvolution of the second-derivative UV-Vis spectrum (OriginPro 2025, Savitzky-Golay smoothing, 2nd-degree polynomial, 9 data points). A batch that spent 18 minutes at 36°C during a chiller malfunction was successfully salvaged by addition of 0.15 eq (relative to porphyrin) of pyridine and cooling to −15°C for 2 hours to dissociate aggregates, verified by full recovery of monomeric Soret absorbance.

Within a high-volume generic benzodiazepine intermediate campaign—specifically involving (2-amino-5-chlorophenyl)(2-fluorophenyl)methanone as a key building block for a midazolam-nucleus—the primary aromatic amine participates in an intramolecular cyclocondensation with glycine ethyl ester hydrochloride but must remain totally inert during an upstream Suzuki-Miyaura cross-coupling with 3-chlorophenylboronic acid catalyzed by Pd(dppf)Cl₂·CH₂Cl₂ (0.6 mol%, 2.0 M aqueous Na₂CO₃, toluene, 85°C, 12 h). The Teoc group installed via 1-({[2-(trimethylsilyl)ethoxy]carbonyl}oxy)pyrrolidine-2,5-dione (1.02 eq, THF with 8% v/v water, NaHCO₃ 1.2 eq, 0–5°C, 3 h) fully suppresses the amine coordination to palladium, which otherwise leads to catalyst sequestration, decreased turnover number (TON drop from 1,300 to 340), and 9–13% aryl-aryl homocoupling byproduct as detected by GC-FID (Agilent 6890N, HP-5 30 m × 0.32 mm, 0.25 µm film, 100–300°C at 15°C/min). Post-coupling, the Teoc-protected intermediate is crystallized from hot isopropanol (82°C dissolution, −5°C crystallization, 8 h aging) to yield a white crystalline solid (mp 127–129°C, Büchi M-565 melting point apparatus, 0.5°C/min gradient). The subsequent glycine ester cyclocondensation proceeds in refluxing acetic acid with sodium acetate buffer (3.5 eq) with the Teoc group intact until the final step, where TBAF-mediated deprotection releases the free amine that spontaneously cyclizes to the 1,4-benzodiazepine 7-membered ring system in 74% overall yield over the two telescoped operations. The chemical process development report, compiled under ICH Q11 for starting material designation and submitted to EDQM via CEP dossier, must contain a full risk assessment for mutagenic impurities: the Teoc-succinimidyl ester is negative in Ames test (OECD 471, Salmonella typhimurium TA98, TA100, TA1535, TA1537 at doses up to 5000 µg/plate with and without S9 metabolic activation), and the pyrrolidine-2,5-dione leaving group is a Class 5 solvent/impurity under ICH M7 (no alert structure, no mutagenicity concern). Nevertheless, its residual level in the final API is controlled at ≤ 0.15% (HPLC-UV 210 nm, external standard method, LOD 0.008%, LOQ 0.025%), consistent with ICH Q3A thresholds for unspecified impurities based on a 2 g/day maximum daily dose.